AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit

Law360, New York (March 8, 2010, 12:25 PM EST) -- An indirect purchaser of Solvay Pharmaceuticals Inc.'s testosterone supplement AndroGel has asked for leave to amend a recently dismissed putative class action accusing the drugmaker of keeping generics rivals out of the market by paying them through patent settlements.

The lead indirect purchaser plaintiff — the Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund — filed a motion Friday in the U.S. District Court for the Northern District of Georgia, arguing it should be allowed to amend its complaint because it was never...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.